Daniela Mihic-Probst

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Ann-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany

|Apr 04, 2025
Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5.

Lyn M Duncan, David E Elder, Michael W Piepkorn

|Sep 23, 2022
Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance.

Umberto Maccio, Alanna Mihic, Daniela Lenggenhager

|Aug 07, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.

Ken Kudura, Florentia Dimitriou, Lucas Basler

|Aug 21, 2019
Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma".

A Curioni-Fontecedro, R Pitocco, N L Schoenewolf

Pageof 2